New data shows Ingrezza Achieves Higher VMAT2 Target Occupancy Than Austedo XR
Recent head-to-head clinical data reveals that Ingrezza demonstrates a significantly higher VMAT2 target occupancy compared to Austedo XR, making it a more effective option in